Cargando…
Pan-cancer analysis identified OAS1 as a potential prognostic biomarker for multiple tumor types
BACKGROUND: 2’,5’-oligoadenylate synthetase 1 (OAS1), has been reported as a tumor driver gene in breast carcinoma and pancreatic carcinoma. However, the role of OAS1 in most tumors has not been reported. METHODS: The original data of 35 tumor types were down load from the TCGA (The Cancer Genome At...
Autores principales: | Jiang, Shan, Deng, Xinzhou, Luo, Ming, Zhou, Le, Chai, Jingjing, Tian, Chao, Yan, Yutao, Luo, Zhiguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511872/ https://www.ncbi.nlm.nih.gov/pubmed/37746262 http://dx.doi.org/10.3389/fonc.2023.1207081 |
Ejemplares similares
-
GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma
por: Han, Jiahui, et al.
Publicado: (2021) -
GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma
por: Song, Shimao, et al.
Publicado: (2022) -
Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma
por: Zhang, Fang, et al.
Publicado: (2023) -
Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma
por: Wang, Zhen, et al.
Publicado: (2022) -
Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma
por: Liu, Xuehe, et al.
Publicado: (2023)